Penumbra (PEN) Research & Development (2014 - 2026)
Penumbra's (PEN) quarterly Research & Development came in at $25.4 million in Q2 2026, up 9.38% year-over-year from $23.2 million in Q2 2025, and up 13.47% quarter-over-quarter from $22.4 million in Q1 2026.
Analysis
Penumbra (PEN) Research & Development (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Research & Development for 13 consecutive years, with $25.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Research & Development rose 9.38% year-over-year to $25.4 million in Q2 2026; TTM through Jun 2026 was $92.2 million, a 1.92% increase from a year earlier, with the FY2025 full-year figure at $89.8 million, down 5.29% from the prior year.
- Research & Development was $25.4 million for Q2 2026 at Penumbra, up from $22.4 million in the prior quarter.
- Over five years, Research & Development peaked at $25.4 million in Q2 2026 and troughed at $18.0 million in Q4 2022.
- A 5-year average of $22.0 million and a median of $21.9 million in 2023 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 27.41% in 2022, down 65.46% in 2022.
- Over 5 years, Research & Development stood at $18.0 million in 2022, then advanced by 22.14% to $21.9 million in 2023, then declined by 8.81% to $20.0 million in 2024, then grew by 8.92% to $21.8 million in 2025, then gained by 16.53% to $25.4 million in 2026.
- The last three Research & Development figures came in at $25.4 million (Q2 2026), $22.4 million (Q1 2026), and $21.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Penumbra | 12.58 Bn | 11.92 Bn | 264.94 Mn | 25.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.40 Mn |
| Mar 31, 2026 | 22.38 Mn |
| Dec 31, 2025 | 21.79 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 23.22 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 25.21 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 21.94 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 21.54 Mn |
| Mar 31, 2023 | 19.99 Mn |
| Dec 31, 2022 | 17.96 Mn |
| Sep 30, 2022 | 21.32 Mn |
| Jun 30, 2022 | 19.56 Mn |
| Mar 31, 2022 | 20.56 Mn |
| Dec 31, 2021 | 52.00 Mn |
| Sep 30, 2021 | 16.73 Mn |